Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4(+) T cells.
Nat Commun.
2024 Mar 5;15(1):2017. doi: 10.1038/s41467-024-46306-8. PubMed PMID:
38443376; PubMed Central PMCID:
PMC10914751.
Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition.
Proc Natl Acad Sci U S A.
2023 Aug 29;120(35):e2305037120. doi: 10.1073/pnas.2305037120. Epub 2023 Aug 21. PubMed PMID:
37603740; PubMed Central PMCID:
PMC10629583.
Architectural basis for cylindrical self-assembly governing Plk4-mediated centriole duplication in human cells.
Commun Biol.
2023 Jul 11;6(1):712. doi: 10.1038/s42003-023-05067-8. PubMed PMID:
37433832; PubMed Central PMCID:
PMC10336005.
Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs.
ACS Pharmacol Transl Sci.
2023 Mar 10;6(3):422-446. doi: 10.1021/acsptsci.2c00250. eCollection 2023 Mar 10. PubMed PMID:
36926457; PubMed Central PMCID:
PMC10012257.
Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1.
J Med Chem.
2022 Feb 10;65(3):1915-1932. doi: 10.1021/acs.jmedchem.1c01359. Epub 2022 Jan 14. PubMed PMID:
35029981; PubMed Central PMCID:
PMC10411393.
ER-associated CTRP1 regulates mitochondrial fission via interaction with DRP1.
Exp Mol Med.
2021 Nov;53(11):1769-1780. doi: 10.1038/s12276-021-00701-z. Epub 2021 Nov 26. PubMed PMID:
34837016; PubMed Central PMCID:
PMC8639813.
Centrosomes in the spotlight: from organization to function to role in disease.
Curr Opin Struct Biol.
2021 Feb;66:iii-v. doi: 10.1016/j.sbi.2021.01.001. Epub 2021 Jan 20. PubMed PMID:
33485756.
Constructing PCM with architecturally distinct higher-order assemblies.
Curr Opin Struct Biol.
2021 Feb;66:66-73. doi: 10.1016/j.sbi.2020.09.013. Epub 2020 Nov 8. Review. PubMed PMID:
33176265.
Autophosphorylation-induced self-assembly and STIL-dependent reinforcement underlie Plk4's ring-to-dot localization conversion around a human centriole.
Cell Cycle.
2020 Dec;19(24):3419-3436. doi: 10.1080/15384101.2020.1843772. Epub 2020 Dec 15. PubMed PMID:
33323015; PubMed Central PMCID:
PMC7781628.
Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models.
J Med Chem.
2020 Dec 10;63(23):14905-14920. doi: 10.1021/acs.jmedchem.0c01451. Epub 2020 Nov 3. PubMed PMID:
33142063; PubMed Central PMCID:
PMC8919061.
Phase separation of the Cep63•Cep152 complex underlies the formation of dynamic supramolecular self-assemblies at human centrosomes.
Cell Cycle.
2020 Dec;19(24):3437-3457. doi: 10.1080/15384101.2020.1843777. Epub 2020 Nov 18. PubMed PMID:
33208041; PubMed Central PMCID:
PMC7781590.
Identification of a New Heterocyclic Scaffold for Inhibitors of the Polo-Box Domain of Polo-like Kinase 1.
J Med Chem.
2020 Nov 25;63(22):14087-14117. doi: 10.1021/acs.jmedchem.0c01669. Epub 2020 Nov 11. PubMed PMID:
33175530; PubMed Central PMCID:
PMC7769008.
A self-assembled cylindrical platform for Plk4-induced centriole biogenesis.
Open Biol.
2020 Aug;10(8):200102. doi: 10.1098/rsob.200102. Epub 2020 Aug 19. Review. PubMed PMID:
32810424; PubMed Central PMCID:
PMC7479937.
Requirement of the Cep57-Cep63 Interaction for Proper Cep152 Recruitment and Centriole Duplication.
Mol Cell Biol.
2020 Apr 28;40(10). doi: 10.1128/MCB.00535-19. Print 2020 Apr 28. PubMed PMID:
32152252; PubMed Central PMCID:
PMC7189096.
Phase separation of Polo-like kinase 4 by autoactivation and clustering drives centriole biogenesis.
Nat Commun.
2019 Oct 31;10(1):4959. doi: 10.1038/s41467-019-12619-2. PubMed PMID:
31672968; PubMed Central PMCID:
PMC6823436.
Molecular architecture of a cylindrical self-assembly at human centrosomes.
Nat Commun.
2019 Mar 11;10(1):1151. doi: 10.1038/s41467-019-08838-2. PubMed PMID:
30858376; PubMed Central PMCID:
PMC6411776.
Mechanism of the natural product moracin-O derived MO-460 and its targeting protein hnRNPA2B1 on HIF-1α inhibition.
Exp Mol Med.
2019 Feb 12;51(2):1-14. doi: 10.1038/s12276-018-0200-4. PubMed PMID:
30755586; PubMed Central PMCID:
PMC6372683.
Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions.
J Biol Chem.
2018 Jan 19;293(3):847-862. doi: 10.1074/jbc.M117.802587. Epub 2017 Nov 30. PubMed PMID:
29191835; PubMed Central PMCID:
PMC5777258.
Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents.
F1000Res.
2017;6:1024. doi: 10.12688/f1000research.11398.1. eCollection 2017. Review. PubMed PMID:
28721210; PubMed Central PMCID:
PMC5497816.
Recruitment of PP1 to the centrosomal scaffold protein CEP192.
Biochem Biophys Res Commun.
2017 Mar 18;484(4):864-870. doi: 10.1016/j.bbrc.2017.02.004. Epub 2017 Feb 8. PubMed PMID:
28188792; PubMed Central PMCID:
PMC7888556.
Anticancer activity of a novel small molecule tubulin inhibitor STK899704.
PLoS One.
2017;12(3):e0173311. doi: 10.1371/journal.pone.0173311. eCollection 2017. PubMed PMID:
28296906; PubMed Central PMCID:
PMC5351965.
Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.
Trends Pharmacol Sci.
2015 Dec;36(12):858-877. doi: 10.1016/j.tips.2015.08.013. Epub 2015 Oct 17. Review. PubMed PMID:
26478211; PubMed Central PMCID:
PMC4684765.
Neighbor-directed histidine N (τ)-alkylation: A route to imidazolium-containing phosphopeptide macrocycles.
Biopolymers.
2015 Nov;104(6):663-73. doi: 10.1002/bip.22698. PubMed PMID:
26152807; PubMed Central PMCID:
PMC4865893.
Putting a bit into the polo-box domain of polo-like kinase 1.
J Anal Sci Technol.
2015;6(1):27. doi: 10.1186/s40543-015-0069-y. Epub 2015 Oct 14. Review. PubMed PMID:
26500787; PubMed Central PMCID:
PMC4610673.
Bimodal Interaction of Mammalian Polo-Like Kinase 1 and a Centrosomal Scaffold, Cep192, in the Regulation of Bipolar Spindle Formation.
Mol Cell Biol.
2015 Aug;35(15):2626-40. doi: 10.1128/MCB.00068-15. PubMed PMID:
26012549; PubMed Central PMCID:
PMC4524112.
Control of the pericentrosomal H2O2 level by peroxiredoxin I is critical for mitotic progression.
J Cell Biol.
2015 Jul 6;210(1):23-33. doi: 10.1083/jcb.201412068. PubMed PMID:
26150388; PubMed Central PMCID:
PMC4493999.
Structural analysis of the polo-box domain of human Polo-like kinase 2.
Proteins.
2015 Jul;83(7):1201-8. doi: 10.1002/prot.24804. Epub 2015 Apr 28. PubMed PMID:
25846005; PubMed Central PMCID:
PMC7720676.
Mammalian Polo-like kinase 1 (Plk1) promotes proper chromosome segregation by phosphorylating and delocalizing the PBIP1·CENP-Q complex from kinetochores.
J Biol Chem.
2015 Mar 27;290(13):8569-81. doi: 10.1074/jbc.M114.623546. Epub 2015 Feb 10. PubMed PMID:
25670858; PubMed Central PMCID:
PMC4375506.
Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity-dependent suicidal inhibition of its polo-box domain.
Cell Cycle.
2015;14(22):3624-34. doi: 10.1080/15384101.2015.1104435. PubMed PMID:
26513691; PubMed Central PMCID:
PMC4825759.
Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells.
Biopolymers.
2014 Nov;102(6):444-55. doi: 10.1002/bip.22569. PubMed PMID:
25283071; PubMed Central PMCID:
PMC4895914.
Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1.
PLoS One.
2014;9(9):e107432. doi: 10.1371/journal.pone.0107432. eCollection 2014. PubMed PMID:
25211362; PubMed Central PMCID:
PMC4161390.
Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis.
Nat Struct Mol Biol.
2014 Aug;21(8):696-703. doi: 10.1038/nsmb.2846. Epub 2014 Jun 29. PubMed PMID:
24997597; PubMed Central PMCID:
PMC4125498.
Mechanisms underlying Plk1 polo-box domain-mediated biological processes and their physiological significance.
Mol Cells.
2014 Apr;37(4):286-94. doi: 10.14348/molcells.2014.0002. Epub 2014 Apr 7. Review. PubMed PMID:
24722413; PubMed Central PMCID:
PMC4012076.
Asymmetric spindle pole formation in CPAP-depleted mitotic cells.
Biochem Biophys Res Commun.
2014 Feb 21;444(4):644-50. doi: 10.1016/j.bbrc.2014.01.129. Epub 2014 Feb 1. PubMed PMID:
24491538; PubMed Central PMCID:
PMC7667489.
Hierarchical recruitment of Plk4 and regulation of centriole biogenesis by two centrosomal scaffolds, Cep192 and Cep152.
Proc Natl Acad Sci U S A.
2013 Dec 10;110(50):E4849-57. doi: 10.1073/pnas.1319656110. Epub 2013 Nov 25. PubMed PMID:
24277814; PubMed Central PMCID:
PMC3864335.
Discovery of novel histidine-derived lipo-amino acids: applied in the synthesis of ultra-short antimicrobial peptidomimetics having potent antimicrobial activity, salt resistance and protease stability.
Eur J Med Chem.
2013 Oct;68:10-8. doi: 10.1016/j.ejmech.2013.07.008. Epub 2013 Jul 26. PubMed PMID:
23933046.
Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.
Bioorg Med Chem Lett.
2013 Aug 15;23(16):4633-6. doi: 10.1016/j.bmcl.2013.06.016. Epub 2013 Jun 14. PubMed PMID:
23816372.
BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress.
Cell Cycle.
2013 Jul 15;12(14):2255-65. doi: 10.4161/cc.25349. PubMed PMID:
24067368; PubMed Central PMCID:
PMC3755076.
Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position.
Bioorg Med Chem.
2013 Jul 15;21(14):3996-4003. doi: 10.1016/j.bmc.2012.05.036. Epub 2012 May 26. PubMed PMID:
22743087; PubMed Central PMCID:
PMC3462889.
Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.
Bioorg Med Chem.
2013 May 1;21(9):2623-34. doi: 10.1016/j.bmc.2013.02.020. Epub 2013 Feb 27. PubMed PMID:
23498919; PubMed Central PMCID:
PMC7561269.
Functional consequences of Wnt-induced dishevelled 2 phosphorylation in canonical and noncanonical Wnt signaling.
J Biol Chem.
2013 Mar 29;288(13):9428-37. doi: 10.1074/jbc.M112.448480. Epub 2013 Feb 8. PubMed PMID:
23396967; PubMed Central PMCID:
PMC3611012.
Essential role of Cenexin1, but not Odf2, in ciliogenesis.
Cell Cycle.
2013 Feb 15;12(4):655-62. doi: 10.4161/cc.23585. Epub 2013 Jan 23. PubMed PMID:
23343771; PubMed Central PMCID:
PMC3594266.
Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast.
Cell Signal.
2013 Feb;25(2):552-60. doi: 10.1016/j.cellsig.2012.11.015. Epub 2012 Nov 23. PubMed PMID:
23178987; PubMed Central PMCID:
PMC3593652.
Oligomycin A enhances apoptotic effect of TRAIL through CHOP-mediated death receptor 5 expression.
Mol Carcinog.
2013 Feb;52(2):85-93. doi: 10.1002/mc.21831. Epub 2011 Nov 15. PubMed PMID:
23335397.
STK295900, a dual inhibitor of topoisomerase 1 and 2, induces G(2) arrest in the absence of DNA damage.
PLoS One.
2013;8(1):e53908. doi: 10.1371/journal.pone.0053908. Epub 2013 Jan 22. PubMed PMID:
23349762; PubMed Central PMCID:
PMC3551932.
Regulation of CEP131 gene expression by SP1.
Gene.
2013 Jan 15;513(1):75-81. doi: 10.1016/j.gene.2012.10.074. Epub 2012 Nov 5. PubMed PMID:
23137637.
Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1).
Bioorg Med Chem Lett.
2012 Dec 15;22(24):7306-8. doi: 10.1016/j.bmcl.2012.10.093. Epub 2012 Oct 27. PubMed PMID:
23159568; PubMed Central PMCID:
PMC3530200.
Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1.
Chembiochem.
2012 Jun 18;13(9):1291-6. doi: 10.1002/cbic.201200206. Epub 2012 May 8. PubMed PMID:
22570300; PubMed Central PMCID:
PMC4536914.
Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway.
EMBO J.
2012 May 18;31(14):3104-17. doi: 10.1038/emboj.2012.144. PubMed PMID:
22609948; PubMed Central PMCID:
PMC3400010.
Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification.
ACS Chem Biol.
2012 May 18;7(5):805-10. doi: 10.1021/cb200469a. Epub 2012 Feb 14. PubMed PMID:
22292814; PubMed Central PMCID:
PMC3355227.
What would you like to do?